| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 5Developing evidence | 100.0% (5/5) | 60.0% (3/5) | +1.5% | -2.3% | -11.7% |
| 20D | 5Developing evidence | 100.0% (5/5) | 80.0% (4/5) | +29.4% | +18.3% | -20.2% |
| 60D | 5Developing evidence | 100.0% (5/5) | 40.0% (2/5) | -15.6% | -5.2% | -16.1% |
| 120D | 5Developing evidence | 100.0% (5/5) | 0.0% (0/5) | -29.3% | -32.4% | -57.8% |
COMPANY RESEARCH
Nanologica AB (publ)
NICA.ST · Sweden · Healthcare · Biotechnology
INSIDER SIGNAL
Insider activity score：39.2 / 100
This is a ranking under the current European screening rules—not a probability of gain, return forecast, or buy recommendation.
Insider vs stock price
No daily prices and volumes have been captured for this stock yet.
Insider timeline
The current window holds no filing with a trade date.
Why this score? · Model details
Priority = 100 × Σ(fixed weight × 0–1 rule-based input)
| Factor | Weight | This company input | Point contribution |
|---|---|---|---|
| 15-day buyer breadth (count) | 35% | 0.300 | 10.5 |
| Qualified-buy size | 25% | 0.709 | 17.7 |
| Role informativeness (inverted) | 20% | 0.050 | 1.0 |
| Recency | 10% | 0.000 | 0.0 |
| Buy/sell conviction | 10% | 1.000 | 10.0 |
This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.
BULL VS BEAR
Two readings of this buying
The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.
Since 2026-10-13: new on the bear side: price trails its sector; no longer on the bear side: associated persons buying, usual level for this company. All bull and bear lists, and what followed each line in the past →
Where the evidence comes from
The purchases themselves carry no bull line, and share price and trading argue against (price down over six months, price trails its sector). No data is held for: company results, company actions.
- The insider purchases themselvesBearone buyer only, latest purchase is old2 checked, under the threshold
- Share price and tradingBearprice down over six months, price trails its sector
- Short sellers1 checked, under the threshold
- Company results2 missing
- Company actionsno data held
Bull case · the buying is informative
Nothing held here goes beyond the fact that an insider bought.
Bear case · discount it
- Only one insider bought. A single purchase can reflect that person's own finances rather than a view on the company.Record: after 4,732 earlier disclosures like this, the median 60-session excess return was −2.7%, within 1 percentage point of all comparable disclosures (−3.3%).
- The latest purchase was 180 days ago (2026-04-20). A reporting period has passed since, so what the buyers knew then may already be public.
- Share price and tradingThe share price is down 20% over six months (three months −37%, one month −16%). Insiders have bought into a fall the market has not reversed.Record (nearest stored case: price 20% or more below its prior 52-week high): after 11,077 earlier disclosures like this, the median 60-session excess return was −3.2%, within 1 percentage point of all comparable disclosures (−2.6%).
- Share price and tradingOver three months the share price changed −37% and the median of 271 Healthcare companies changed −6.3%: 31 points behind. The market has marked this company down against its own sector.
Evidence still missing
- The company's market value is not captured, so the purchases cannot be stated as a share of the business or of its trading volume.
- No earnings, margin or cash-flow figures are captured for this company. The latest annual and interim reports are where to check whether the business is improving or deteriorating.
Checked and under the threshold: 3
- EitherNet purchases of €56k in 180 days. Bull from €1.0M, bear when all purchases total under €25k.
- BearNo insider sale is recorded in the same 180 days.
- BearThe register of Finansinspektionen shows no published net short position in this company. Positions under 0.5% are never published, so this does not show that nobody is short.
Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.
Signal history
39.2 / 100
Latest recorded score
↓ -15.4 ptsversus the comparable snapshot on 2026-09-14 (34 calendar days apart)
- Recorded snapshots
- 35
- First snapshot
- 2026-08-26
Only scores captured when the scoring run completed are compared. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.
Why did it change?
Decomposition across the five score factors between comparable snapshots; historical scores are not recalculated.
- Cluster-10.5 pts
- Purchase size-4.9 pts
Signal score history
Fixed 0–100 scale; dates are spaced by calendar time.
Recent recorded points
- 62.7
- 63.6
- 39.2
- 39.2
- 39.2
View all recorded scores
| Snapshot date | Signal score |
|---|---|
| 2026-08-26 | 62.7 |
| 2026-08-27 | 62.7 |
| 2026-08-28 | 62.6 |
| 2026-08-31 | 62.6 |
| 2026-09-01 | 62.6 |
| 2026-09-02 | 62.6 |
| 2026-09-03 | 62.6 |
| 2026-09-04 | 62.6 |
| 2026-09-07 | 63.6 |
| 2026-09-08 | 63.6 |
| 2026-09-09 | 63.6 |
| 2026-09-10 | 63.6 |
| 2026-09-11 | 63.6 |
| 2026-09-14 | 54.6 |
| 2026-09-23 | 54.6 |
| 2026-09-24 | 40.9 |
| 2026-09-25 | 40.9 |
| 2026-09-28 | 39.2 |
| 2026-09-29 | 39.2 |
| 2026-09-30 | 39.2 |
| 2026-10-01 | 39.2 |
| 2026-10-02 | 39.2 |
| 2026-10-03 | 39.2 |
| 2026-10-04 | 39.2 |
| 2026-10-05 | 39.2 |
| 2026-10-06 | 39.2 |
| 2026-10-07 | 39.2 |
| 2026-10-08 | 39.2 |
| 2026-10-09 | 39.2 |
| 2026-10-12 | 39.2 |
| 2026-10-13 | 39.2 |
| 2026-10-14 | 39.2 |
| 2026-10-15 | 39.2 |
| 2026-10-16 | 39.2 |
| 2026-10-18 | 39.2 |
Why there is no buy signal
No qualifying open-market purchase disclosure is available in the current research window. This is not a sell signal.
The underlying disclosures remain available below for audit.
Sector context
- Buying breadth
- 6.1% (48 / 792 issuers)
- Sector rank
- #11 / 12
- 7D breadth change
- -0.4 pp · vs 2026-10-12 (6d)
- 30D breadth change
- History building
This is sector-level research context. It does not affect the Insider Signal or ranking.
Insider profile outcomes
Historical performance following insider filings. The company role is translated below each name while preserving the original title.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = completed events with positive excess return ÷ total completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
- Small-sample rule: n<5 is shown for transparency and is not scored.
Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -27.0% | -27.0% | -48.5% |
| 20D | 2Small sample | 100.0% (2/2) | 50.0% (1/2) | +2.9% | +2.9% | -30.7% |
| 60D | 2Small sample | 100.0% (2/2) | 50.0% (1/2) | -16.0% | -16.0% | -58.8% |
| 120D | 2Small sample | 100.0% (2/2) | 0.0% (0/2) | -54.8% | -54.8% | -78.0% |
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -14.4% | -14.4% | -14.4% |
| 20D | 1Small sample | 100.0% (1/1) | 100.0% (1/1) | +151.0% | +151.0% | +151.0% |
| 60D | 1Small sample | 100.0% (1/1) | 100.0% (1/1) | +28.9% | +28.9% | +28.9% |
| 120D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -31.0% | -31.0% | -31.0% |
Market context
PRICE PERFORMANCE
VOLATILITY & LIQUIDITY
- Volatility
- 142.2%
- Beta
- —
- Avg daily volume
- SEK 142,388.6
VALUATION
- Market cap
- —
- P/E
- —
FUNDAMENTALS
- Profit margin
- -451.4%
- ROE
- -88.6%
- Industry
- —
Prices to 07 Oct 2026: price cache (Eulerpool). From the company's annual report ↗, fiscal year ended 31 Dec 2024: Profit margin, ROE. It does not affect the insider score or rank.
Disclosed net short positions
The Finansinspektionen register, read 18 Oct 2026, publishes no net short position of 0.5% or more in this issuer. Positions below 0.5% are never published, so this is not evidence that nobody is short.
Short-position disclosures are external context; they do not affect the insider score, ranking, or filing eligibility.
Insiders' buying price vs the latest close
The latest close in the price history is more than a week old.
Buying size vs market trading
Market history is too old for this snapshot; ratios are withheld.
Market-data coverage: 250 verified sessions · Latest session: 2026-10-07 · Ratio status: Unavailable
Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.
Latest news
No news has been captured for this company.
Regulatory filings
The filing records held for this company carry no link to the original notice.
Filing evidence
These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.
Excluded transactions & classification
4 qualifying purchase disclosure(s) · 4 transaction line(s)
Apr 20, 2026Förvärv
Andreas Bhagwani · Verkställande direktör (VD)
Aktie · 2600000.0 shares × 0.4 SEK · —
Mar 30, 2026Förvärv
Andreas Bhagwani · Verkställande direktör (VD)
Aktie · 4900000.0 shares × 0.4 SEK · —
Mar 27, 2026Teckning
Thomas Eldered · Styrelseledamot
BTA (betald tecknad aktie) · 89872048.0 shares × 0.40 SEK · —
Unfold all 1 remaining filing row(s)
| Transaction date | Published | Filer | Role | Transaction | Instrument | Price (local currency) | Quote currency | Volume | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-20 | Jeremie Trochu | Styrelseledamot | Teckning | Aktie | 0.4 SEK | SEK | 21453780.0 | — |
Showing 4 of 4 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Other disclosed transactions · excluded from score
View 1 other transaction(s)
Mar 27, 2026Lösen minskning
Thomas Eldered · Styrelseledamot
Teckningsrätt/Uniträtt · 38516592.0 shares × 0.0 SEK · —
Showing 1 of 1 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Snapshot & identity
- Snapshot date
- 2026-10-18
- Ticker
- NICA.ST
- ISIN
- SE0005454873
- Sector
- Healthcare
- Industry
- Biotechnology
Company logos by Parqet